417 related articles for article (PubMed ID: 27013929)
1. Antiangiogenic mechanisms and factors in breast cancer treatment.
Castañeda-Gill JM; Vishwanatha JK
J Carcinog; 2016; 15():1. PubMed ID: 27013929
[TBL] [Abstract][Full Text] [Related]
2. The Epigenetic Profile of Tumor Endothelial Cells. Effects of Combined Therapy with Antiangiogenic and Epigenetic Drugs on Cancer Progression.
Ciesielski O; Biesiekierska M; Panthu B; Vialichka V; Pirola L; Balcerczyk A
Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32283668
[TBL] [Abstract][Full Text] [Related]
3. Role of anti-angiogenic factors in the pathogenesis of breast cancer: A review of therapeutic potential.
Ruan L; Zhang S; Chen X; Liang W; Xie Q
Pathol Res Pract; 2022 Aug; 236():153956. PubMed ID: 35700578
[TBL] [Abstract][Full Text] [Related]
4. Angiogenesis in cancer: molecular mechanisms, clinical impact.
Eichhorn ME; Kleespies A; Angele MK; Jauch KW; Bruns CJ
Langenbecks Arch Surg; 2007 May; 392(3):371-9. PubMed ID: 17458577
[TBL] [Abstract][Full Text] [Related]
5. A novel assay to assess the effectiveness of antiangiogenic drugs in human breast cancer.
Lyons JM; Anthony CT; Thomson JL; Woltering EA
Ann Surg Oncol; 2008 Dec; 15(12):3407-14. PubMed ID: 18795370
[TBL] [Abstract][Full Text] [Related]
6. Tumor response to ionizing radiation combined with antiangiogenesis or vascular targeting agents: exploring mechanisms of interaction.
Wachsberger P; Burd R; Dicker AP
Clin Cancer Res; 2003 Jun; 9(6):1957-71. PubMed ID: 12796357
[TBL] [Abstract][Full Text] [Related]
7. [Expert consensus on off-label use of small molecule anti-angiogenic drugs in the treatment of metastatic breast cancer].
;
Zhonghua Zhong Liu Za Zhi; 2022 Jun; 44(6):523-530. PubMed ID: 35754226
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic application of anti-angiogenic nanomaterials in cancers.
Mukherjee S; Patra CR
Nanoscale; 2016 Jul; 8(25):12444-70. PubMed ID: 27067119
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of angiogenic factors in breast cancer.
Locopo N; Fanelli M; Gasparini G
Breast Cancer Res Treat; 1998; 52(1-3):159-73. PubMed ID: 10066080
[TBL] [Abstract][Full Text] [Related]
10. Effects of conventional neoadjuvant chemotherapy for breast cancer on tumor angiogenesis.
Luengo-Gil G; González-Billalabeitia E; Chaves-Benito A; García Martínez E; García Garre E; Vicente V; Ayala de la Peña F
Breast Cancer Res Treat; 2015 Jun; 151(3):577-87. PubMed ID: 25967462
[TBL] [Abstract][Full Text] [Related]
11. Acquired tumor resistance to antiangiogenic therapy: Mechanisms at a glance.
Zarrin B; Zarifi F; Vaseghi G; Javanmard SH
J Res Med Sci; 2017; 22():117. PubMed ID: 29184575
[TBL] [Abstract][Full Text] [Related]
12. Relationship between hypoxia and response to antiangiogenic therapy in metastatic colorectal cancer.
Ulivi P; Marisi G; Passardi A
Oncotarget; 2016 Jul; 7(29):46678-46691. PubMed ID: 27081084
[TBL] [Abstract][Full Text] [Related]
13. Antiangiogenic drugs: current knowledge and new approaches to cancer therapy.
Mauriz JL; González-Gallego J
J Pharm Sci; 2008 Oct; 97(10):4129-54. PubMed ID: 18200520
[TBL] [Abstract][Full Text] [Related]
14. [Role of angiogenesis in the growth and progression of tumors. Treatment with angiogenesis inhibitors: from promising results in experimental animal models to the reality of clinical use].
Plavetić ND; Letilović T; Vrbanec D
Lijec Vjesn; 2003; 125(9-10):260-5. PubMed ID: 15038217
[TBL] [Abstract][Full Text] [Related]
15. Antiangiogenic therapy.
Albo D; Wang TN; Tuszynski GP
Curr Pharm Des; 2004; 10(1):27-37. PubMed ID: 14754403
[TBL] [Abstract][Full Text] [Related]
16. Combination antiangiogenic therapy and radiation in head and neck cancers.
Hsu HW; Wall NR; Hsueh CT; Kim S; Ferris RL; Chen CS; Mirshahidi S
Oral Oncol; 2014 Jan; 50(1):19-26. PubMed ID: 24269532
[TBL] [Abstract][Full Text] [Related]
17. Antineovascular therapy, a novel antiangiogenic approach.
Shimizu K; Asai T; Oku N
Expert Opin Ther Targets; 2005 Feb; 9(1):63-76. PubMed ID: 15757482
[TBL] [Abstract][Full Text] [Related]
18. Angiogenic role of miR-20a in breast cancer.
Luengo-Gil G; Gonzalez-Billalabeitia E; Perez-Henarejos SA; Navarro Manzano E; Chaves-Benito A; Garcia-Martinez E; Garcia-Garre E; Vicente V; Ayala de la Peña F
PLoS One; 2018; 13(4):e0194638. PubMed ID: 29617404
[TBL] [Abstract][Full Text] [Related]
19. Reappraising antiangiogenic therapy for breast cancer.
Kerbel RS
Breast; 2011 Oct; 20 Suppl 3(0 3):S56-60. PubMed ID: 22015294
[TBL] [Abstract][Full Text] [Related]
20. Targeting Angiogenesis in Breast Cancer: Current Evidence and Future Perspectives of Novel Anti-Angiogenic Approaches.
Ayoub NM; Jaradat SK; Al-Shami KM; Alkhalifa AE
Front Pharmacol; 2022; 13():838133. PubMed ID: 35281942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
